Lifecore Biomedical, Inc.
LFCR
$6.38
$0.213.40%
NASDAQ
02/23/2025 | 11/24/2024 | 08/25/2024 | 05/26/2024 | 02/25/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 5.42M | 9.46M | 5.52M | 8.46M | 3.07M |
Total Receivables | 41.65M | 30.30M | 25.15M | 31.15M | 31.45M |
Inventory | 34.60M | 39.21M | 41.64M | 39.98M | 39.67M |
Prepaid Expenses | 2.55M | 2.89M | 1.88M | 1.44M | 1.97M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 84.21M | 81.86M | 74.18M | 81.03M | 76.16M |
|
|||||
Total Current Assets | 84.21M | 81.86M | 74.18M | 81.03M | 76.16M |
Net Property, Plant & Equipment | 126.01M | 152.88M | 151.13M | 151.04M | 147.88M |
Long-term Investments | 13.88M | 13.88M | 13.88M | 13.88M | 13.88M |
Goodwill | 13.88M | 13.88M | 13.88M | 13.88M | 13.88M |
Total Other Intangibles | 4.20M | 4.20M | 4.20M | 4.20M | 4.20M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 9.40M | 2.57M | 3.43M | 3.81M | 4.13M |
Total Assets | 237.69M | 255.39M | 246.82M | 253.96M | 246.24M |
|
|||||
Total Accounts Payable | 7.41M | 14.97M | 18.01M | 16.33M | 15.69M |
Total Accrued Expenses | 9.74M | 11.48M | 13.36M | 15.52M | 12.96M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 4.90M | 4.89M | 4.91M | 4.91M | 4.93M |
Total Finance Division Other Current Liabilities | 9.07M | 3.95M | 4.24M | 2.11M | 3.23M |
Total Other Current Liabilities | 9.07M | 3.95M | 4.24M | 2.11M | 3.23M |
Total Current Liabilities | 31.12M | 35.29M | 40.52M | 38.87M | 36.81M |
|
|||||
Total Current Liabilities | 31.12M | 35.29M | 40.52M | 38.87M | 36.81M |
Long-Term Debt | 118.16M | 119.03M | 127.15M | 120.51M | 116.25M |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 7.28M | 7.42M | 4.80M | 4.94M | 5.09M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 33.71M | 33.89M | 34.85M | 35.73M | 28.66M |
Total Liabilities | 190.27M | 195.63M | 207.32M | 200.06M | 186.81M |
|
|||||
Common Stock & APIC | 206.32M | 206.91M | 178.82M | 177.84M | 177.13M |
Retained Earnings | -204.09M | -191.46M | -182.75M | -166.52M | -159.44M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 2.23M | 15.45M | -3.94M | 11.32M | 17.69M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | 45.20M | 44.31M | 43.44M | 42.59M | 41.75M |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | 45.20M | 44.31M | 43.44M | 42.59M | 41.75M |
|
|||||
Total Common Equity | 2.23M | 15.45M | -3.94M | 11.32M | 17.69M |
Total Preferred Equity | 45.20M | 44.31M | 43.44M | 42.59M | 41.75M |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 47.43M | 59.76M | 39.50M | 53.90M | 59.43M |
|